Applied Cells specializes in advanced technologies for cell isolation, focusing on enhancing research in areas such as multiple myeloma, stem cell studies, and cell therapy development. Their proprietary MARS (Microfluidic Acoustic Resonance Separation) platform utilizes innovative acoustic and magnetic separation techniques to efficiently isolate various cell types, including CD138+ plasma cells and CD34+ hematopoietic stem cells. This platform is designed to streamline workflows by eliminating the need for traditional methods like centrifugation and Ficoll separation, thereby maximizing cell recovery and purity. The MARS system is also compliant with regulatory standards, ensuring its suitability for clinical applications.

The company emphasizes its commitment to rare cell research and offers a comprehensive suite of reagents and instruments tailored for diverse applications, including the isolation of immune cells such as T cells, B cells, and monocytes. Their Ingenuity™ 50nm superparamagnetic beads, used in conjunction with the MARS platform, facilitate the isolation of monocytes for further differentiation into dendritic cells and macrophages, which are crucial for immunotherapy. By providing robust and reproducible isolation methods, Applied Cells aims to empower researchers and clinicians in their pursuit of precision medicine and innovative therapeutic solutions.

United States

Applied Cells, Inc., was founded in 2018 in Silicon Valley to create revolutionary solutions to cell separationÂ and enrichment products,Â which increase cell separation efficiently by changing how physics is employed in the process.Â We are supporting industry experts in Cell Therapy Development with MARSÂ® immunomagnetic cell separation Platform. Our innovative, column-free, immunomagnetic cell iso

Applied Cells

Company Details